PHARMACOPHORE MODELING AND ATOM-BASED 3D-QSAR STUDIES OF ANTIFUNGAL BENZOFURANS
Keywords:PHASE, Ligand based pharmacophore, Atom based 3D-QSAR, Nmt Inhibitors
A novel series of benzofuran analogs was reported as nonpeptidic Myristoyl-CoA: protein N -myristoyltransferase (Nmt) inhibitors. To find out the common structural requirement of these benzofurans inhibitors, a ligand based pharmacophore and atom-based 3D-QSAR model was generated. A five-point pharmacophore model was developed with two hydrogen bond acceptors (AA), one positive ionic atom (P) and two aromatic ring residues (RR). This is denoted as AAPRR. A statistically significant 3D-QSAR model for training set of 24 compounds was obtained using this pharmacophore hypothesis with correlation coefficient (r2 = 0.916) and high Fisher ratio (F =113.9). Also, the predictive power of generated model for test set of 5 compounds was found to be significant which was confirmed by the high value of cross validated correlation coefficient (q2 = 0.804) and Pearson-R (0.917). The results of ligand based pharmacophore hypothesis and atom based 3D-QSAR model explore the detailed structural perceptivities and also highlights the important binding features of benzofurans with Nmt.
Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499-511.
Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12:310-50.
Steenbergen JN, Casadevall AJ. Prevalence of Cryptococcus neoformans var neoformans (Serotype D) and cryptococcus neoformans var grubii (Serotype A) isolates in New York City. Clin Microbiol 2000;38:1974-6.
Duronio RJ, Towler DA, Heuckeroth RO, Gordon JI. Disruption of the yeast N-myristoyl transferase gene causes recessive lethality. Sci 1989;243:796-800.
Weinberg RA, McWherter CA, Freeman SK, Wood DC, Gordon JI, Lee SC. Genetic studies reveal that myristoyl Co A: protein N-myristoyltransferase is an essential enzyme in Candida albicans. Mol Microbiol 1995;16:241-50.
Lodge JK, Machelski E, Toffaletti DL, Perfect JR, Gordon JI. Targeted gene replacement demonstrates that myristoyl-Co A: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans. Proc Natl Acad Sci USA 1994;91:12008-12.
Wilcox C, Hu JS, Olson EN. Acylation of proteins with myristic acid occurs cotranslationally. Sci 1987;238:275-8.
Johnson DR, Bhatnagar RS, Knoll LJ, Gordon JI. Genetic and biochemical studies of protein N-myristoylation. Annu Rev Biochem 1994;63:869-914.
Benedetti MS, Bani M. Metabolism-based drug interactions involving oral azole antifungals in humans. Drug Metab Rev 1999;31:665-717.
Talele TT, Kulkarni SS, Kulkarni VM. Development of pharmacophore alignment models as input for comparative molecular field analysis of a diverse set of azole antifungal agents. J Chem Inf Comput Sci 1999;39:958-66.
Gokhale VM, Kulkarni VM. Comparative molecular field analysis of fungal squalene epoxidase inhibitors. J Med Chem 1999;42:5348-58.
Karki RG, Kulkarni VM. A feature based Pharmacophore for Candida albicans MyristoylCoA: protein N-myristoyltransferase inhibitors. Eur J Med Chem 2001b;36:147-63.
Karki RG, Kulkarni VM. Computer-aided design and synthesis of Candida albicans N-myristoyltransferase inhibitors as antifungal agents. Indian Drugs 2001;38:406-13.
Masubuchi M, Ken-ichi K, Ebiike H, Ikeda Y, Tsujii S, Sogabe S, et al. Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase Part 1. Bioorg Med Chem Lett 2001;11:1833-7.
Ebiike H, Masubuchi M, Liu P, Kawasaki K, Morikami K, Sogabe S, et al. Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase Part 2. Bioorg Med Chem Lett 2002;12:607-10.
Ken-ichi K, Masubuchi M, Morikami K, Sogabe S, Aoyama T, Ebiike H, et al. Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase Part 3. Bioorg Med Chem Lett 2003;13:87-91.
Purushottamachar P, Kulkarni VM. 3D-QSAR of N-myristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods. Bioorg Med Chem 2003;5:3487-97.
Deokar HS, Purushottamachar P, Kulkarni VM. QSAR analysis of N-myristoyltransferase inhibitors: antifungal activity of benzofurans. Med Chem Res 2009;18:206-20.
Yang SY. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 2010;15:444-50.
Bhansali SG, Kulkarni VM. Pharmacophore generation, atom-based 3D-QSAR, docking, and virtual screening studies of p38-Î± mitogen activated protein kinase inhibitors: pyridopyridazine-6-ones (part-2). Res Rep Med Chem 2014;4:1-21.
Bhansali SG, Kulkarni VM. 3D-QSAR of p38 mitogen activated protein kinase inhibitors: pyridopyridazine-6-ones (part-1). Res Rep Med Chem 2013;3:29-41.
Bhansali SG, Kulkarni VM. Combined 2D and 3D-QSAR, molecular modeling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitors. SAR QSAR Environ Res 2014;25(11):905-37.
Phase, version 3.4, SchrÃ¶dinger, LLC, New York NY; 2012.
Golbraikh A, Shen M, Xiao Z, Xiao Y, Lee K. Tropsha, A rational selection of training and test sets for the development of validated QSAR models. J Comput Aided Mol Des 2003;17:241-53.
Lig Prep, version 2.5, SchrÃ¶dinger, LLC: New York NY; 2012.
Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetic and properties of organic liquids. J Am Chem Soc 1996;118:11225-36.
Chang G, Guida WC, Still WC. An internal-coordinate monte carlo method for searching conformational space. J Am Chem Soc 1989;111:4379-86.
Kolossvary I, Guida WC. Low mode search. An efficient, automated computational method for conformational analysis: application to cyclic and acyclic alkanes and cyclic peptides. J Am Chem Soc 1996;118:5011-9.
Dixon SL, Smondyrev AM, Knoll EH, Rao SN, Shaw DE, Friesner RA. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 2006;20:647-71.
Dixon SL, Smondyrev AM, Rao S. Phase: a novel approach to pharmacophore modeling and 3d database searching. Chem Biol Drug Des 2006;67:370-2.
Shah UA, Deokar HS, Kadam SS, Kulkarni VM. Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl) pyrimidines as COX-2 inhibitors. Mol Div 2010;14:559-68.
Teli MK. Pharmacophore generation and atom-based 3D-QSAR of N-iso-propyl pyrrole-based derivatives as HMG-CoA reductase inhibitors. Org Med Chem Lett 2012;2:25-34.